GlaxoSmithKline PLC News Headlines

GSK 
$46.98
*  
0.08
0.17%
Get GSK Alerts
*Delayed - data as of Sep. 15, 2014  -  Find a broker to begin trading GSK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Novartis Presents Positive Data on Lucentis and Jetrea - Analyst Blog
9/15/2014 5:35:00 PM - Zacks.com

Five Prime: Option Exercise By Glaxo For License To Muscle Disease Target
9/15/2014 4:23:00 PM - RTT News

Terrific Stocks On Sale: Part 1
9/15/2014 1:03:00 PM - Seeking Alpha

COPD Occurs Most Often in These 5 States
9/14/2014 2:39:02 PM - Motley Fool

30 Bad Boy All Star Dividend Dogs Track 12% August Upsides
9/14/2014 3:39:00 AM - Seeking Alpha

Vectura Group Following A Familiar Path
9/13/2014 8:44:00 AM - Seeking Alpha

Why Amarin Corporation plc Stock Cratered
9/12/2014 10:28:16 AM - Motley Fool

Marijuana & Antidotes: GSK & CEMP Nursing Pulmonary Diseases
9/12/2014 9:40:00 AM - Seeking Alpha

Evaluating GlaxoSmithKline's Intrinsic Value
9/12/2014 7:38:00 AM - Seeking Alpha

Dividend Quick Picks: Foreign Stocks
9/11/2014 4:49:00 PM - Seeking Alpha

Ebola: Desperate Days Ahead
9/11/2014 3:14:00 PM - Seeking Alpha

Gilead Will Continue To Rise
9/11/2014 11:20:00 AM - Seeking Alpha

Ligand Inks 2nd Captisol Deal with CURx Pharmaceuticals - Analyst Blog
9/10/2014 5:00:00 PM - Zacks.com

Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity
9/10/2014 9:36:00 AM - TheStreet

A Top Dividend Stock for Your Portfolio: Johnson & Johnson
9/10/2014 8:37:57 AM - Motley Fool

AstraZeneca Presents Unfavorable Benralizumab Study Data - Analyst Blog
9/9/2014 6:35:00 PM - Zacks.com

Glaxo (GSK) Updates on Asthma Candidate Mepolizumab - Analyst Blog
9/9/2014 6:20:00 PM - Zacks.com

Hunting For The U.K.'s Best Returns
9/9/2014 12:37:00 PM - Seeking Alpha

Scottish Vote Ahead: Dump These 3 Stocks - Analyst Blog
9/9/2014 11:10:00 AM - Zacks.com

Teva Pharmaceuticals New Drug Aims to Reduce Asthma Attacks
9/9/2014 10:01:02 AM - Motley Fool

Why GlaxoSmithKline (GSK) Stock Is Falling Today
9/9/2014 8:17:00 AM - TheStreet

Glaxo Announces EU Nod for Single-Pill HIV Drug Triumeq - Analyst Blog
9/8/2014 5:25:00 PM - Zacks.com

Novartis (NVS) Presents Positive Data on Ultibro Breezhaler - Analyst Blog
9/8/2014 5:05:00 PM - Zacks.com

Ebola Outbreak Strikes Africa: How We're Fighting Back
9/8/2014 1:37:02 PM - Motley Fool

4 Companies To Look At After WHO Ebola Consultation In Geneva
9/8/2014 11:51:00 AM - Seeking Alpha